Global Calcimimetic Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Calcimimetic Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
A calcimimetic is a pharmaceutical drug that mimics the action of calcium on tissues, by allosteric activation of the calcium-sensing receptor that is expressed in various human organ tissues. Calcimimetics are used to treat secondary hyperparathyroidism (SHPT).
Calcimimetic report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Calcimimetic market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Hospital and Clinic are the major drivers for the industry.
The parathyroid gland is an essential gland for human life, and SHPT is a common and serious decompensation disease in patients with chronic kidney disease receiving dialysis treatment, and it is one of the important manifestations of mineral metabolism disorders. According to the 2012 China Epidemiological Survey, the number of patients with middle and end-stage renal disease in China is about 2 million, the dialysis rate is less than 20%, and the conversion rate of SHPT in patients with mineral and bone metabolic disorders (CKD-MBD) is close to 50%. . The dialysis rate is 90% in developed countries (United States, Europe, Japan). Based on this, it can be predicted that in the future, the number of SHPT people will release a large growth space with the improvement of the diagnosis, detection and treatment of chronic kidney disease.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Calcimimetic market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Amgen
Ono Pharmaceutical
Aurobindo Pharma
Roche Holding AG
Lilly
Merck & Co., Inc.
Johnsons & Johnsons
Bristol Myers Squibb
Accord Healthcare , Inc.
Alkem Labs
Viatris
Teva Pharmaceutical Industries Ltd
Segment by Type
Cinacalcet
Etelcalcetide
Evocalcet
Hospital
Clinic
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Calcimimetic market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Calcimimetic, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Calcimimetic industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Calcimimetic in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Calcimimetic introduction, etc. Calcimimetic Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Calcimimetic market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Calcimimetic report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Calcimimetic market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Hospital and Clinic are the major drivers for the industry.
The parathyroid gland is an essential gland for human life, and SHPT is a common and serious decompensation disease in patients with chronic kidney disease receiving dialysis treatment, and it is one of the important manifestations of mineral metabolism disorders. According to the 2012 China Epidemiological Survey, the number of patients with middle and end-stage renal disease in China is about 2 million, the dialysis rate is less than 20%, and the conversion rate of SHPT in patients with mineral and bone metabolic disorders (CKD-MBD) is close to 50%. . The dialysis rate is 90% in developed countries (United States, Europe, Japan). Based on this, it can be predicted that in the future, the number of SHPT people will release a large growth space with the improvement of the diagnosis, detection and treatment of chronic kidney disease.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Calcimimetic market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Amgen
Ono Pharmaceutical
Aurobindo Pharma
Roche Holding AG
Lilly
Merck & Co., Inc.
Johnsons & Johnsons
Bristol Myers Squibb
Accord Healthcare , Inc.
Alkem Labs
Viatris
Teva Pharmaceutical Industries Ltd
Segment by Type
Cinacalcet
Etelcalcetide
Evocalcet
Segment by Application
Hospital
Clinic
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Calcimimetic market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Calcimimetic, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Calcimimetic industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Calcimimetic in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Calcimimetic introduction, etc. Calcimimetic Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Calcimimetic market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices